Search
Displaying 11–20 of 470 results for “fut credit Visitez le site Buyfc26coins.com Support incomparable pour mes FC 26 coins.K5QU”
-
Foundation and Vision Partners Seek Biomedical Research Support from Congress during COVID-19 Crisis
Foundation NewsDelays in Research Impacting Therapy Development
-
Persevering to Success with the Support of Family, Friends, and Faith
Beacon StoriesA story about living with retinitis pigmentosa.
-
Release Date: June 5, 2020 Expiration Date: May 29, 2023
This activity offers CE credit for: a. Physicians (CME) b. Optometrists (COPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™.
-
In the Press
Opus Genetics secures up to $2M in non-dilutive funding from the RD Fund to advance its OPGx-MERTK gene therapy program targeting retinitis pigmentosa caused by MERTK mutations.
-
Foundation News
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for retinal degenerative diseases, will host an online continuing medical education (CME and COPE) course on inherited retinal disease gene therapies on Thursday, June 9, 2022, at 7:00 p.m. EDT.
-
Foundation News
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.
-
The Foundation Fighting Blindness is inviting you to share your vision-loss journey through written word, audio or video as a part of our October “Share Your Vision” campaign. Help your friends, family, and even people you don’t know, see the world through your eyes—because your story is powerful and unique. #ShareYourVision
-
Foundation Fighting Blindness Launches GYROS, a Natural History Study for People with Gyrate Atrophy
Foundation NewsGyrate atrophy is an inherited retinal disease—causing progressive vision loss. GYROS results will help researchers design clinical trials for an emerging gyrate atrophy gene therapy.
-
Foundation News
The inaugural credit-based event will include education on inherited retinal diseases, physician resources, and current clinical trials.
-
Foundation News
Course Title: Clinical Trials of Emerging Therapies for Retinal Degeneration Patients: Hope and Opportunities
